115 related articles for article (PubMed ID: 38752545)
1. c-Cbl induced podocin ubiquitination contributes to the podocytes injury in diabetic nephropathy.
Liang L; He M; Zhou P; Pan S; Chen J; Lv L; Hu M; Zhou S; Liu D; Liu Z
FASEB J; 2024 May; 38(10):e23662. PubMed ID: 38752545
[TBL] [Abstract][Full Text] [Related]
2. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury.
Chen X; Liu W; Xiao J; Zhang Y; Chen Y; Luo C; Huang Q; Peng F; Gong W; Li S; He X; Zhuang Y; Wu N; Liu Y; Wang Y; Long H
FASEB J; 2020 Oct; 34(10):13300-13316. PubMed ID: 32786113
[TBL] [Abstract][Full Text] [Related]
3. Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway.
Kim DY; Kang MK; Lee EJ; Kim YH; Oh H; Kang YH
Mol Nutr Food Res; 2018 Oct; 62(19):e1800302. PubMed ID: 29987888
[TBL] [Abstract][Full Text] [Related]
4. [Changes of podocyte ultrastructure and expression of podocyte-associated molecules in rats with diabetic nephropathy].
Chen LP; Zhou QL; Peng WS; Wu XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):620-5. PubMed ID: 17767053
[TBL] [Abstract][Full Text] [Related]
5. CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes.
Tossidou I; Teng B; Drobot L; Meyer-Schwesinger C; Worthmann K; Haller H; Schiffer M
J Biol Chem; 2010 Aug; 285(33):25285-95. PubMed ID: 20457601
[TBL] [Abstract][Full Text] [Related]
6. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
Cheng Q; Pan J; Zhou ZL; Yin F; Xie HY; Chen PP; Li JY; Zheng PQ; Zhou L; Zhang W; Liu J; Lu LM
Acta Pharmacol Sin; 2021 Jun; 42(6):954-963. PubMed ID: 32968210
[TBL] [Abstract][Full Text] [Related]
7. Silencing of Histone Deacetylase 9 Expression in Podocytes Attenuates Kidney Injury in Diabetic Nephropathy.
Liu F; Zong M; Wen X; Li X; Wang J; Wang Y; Jiang W; Li X; Guo Z; Qi H
Sci Rep; 2016 Sep; 6():33676. PubMed ID: 27633396
[TBL] [Abstract][Full Text] [Related]
8. TangShenWeiNing Formula Prevents Diabetic Nephropathy by Protecting Podocytes Through the SIRT1/HIF-1α Pathway.
Chang J; Zheng J; Gao X; Dong H; Yu H; Huang M; Sun Z; Feng X
Front Endocrinol (Lausanne); 2022; 13():888611. PubMed ID: 35721758
[TBL] [Abstract][Full Text] [Related]
9. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.
Zhang H; Schin M; Saha J; Burke K; Holzman LB; Filipiak W; Saunders T; Xiang M; Heilig CW; Brosius FC
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F91-8. PubMed ID: 20375116
[TBL] [Abstract][Full Text] [Related]
10. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway.
Huang G; Lv J; Li T; Huai G; Li X; Xiang S; Wang L; Qin Z; Pang J; Zou B; Wang Y
Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic cleavage of Podocin by Matriptase exacerbates podocyte injury.
Ozawa S; Matsubayashi M; Nanaura H; Yanagita M; Mori K; Asanuma K; Kajiwara N; Hayashi K; Ohashi H; Kasahara M; Yokoi H; Kataoka H; Mori E; Nakagawa T
J Biol Chem; 2020 Nov; 295(47):16002-16012. PubMed ID: 32907879
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
[TBL] [Abstract][Full Text] [Related]
14. Profile of Podocyte Translatome During Development of Type 2 and Type 1 Diabetic Nephropathy Using Podocyte-Specific TRAP mRNA RNA-seq.
Wang Y; Niu A; Pan Y; Cao S; Terker AS; Wang S; Fan X; Toth CL; Ramirez Solano MA; Michell DL; Contreras D; Allen RM; Zhu W; Sheng Q; Fogo AB; Vickers KC; Zhang MZ; Harris RC
Diabetes; 2021 Oct; 70(10):2377-2390. PubMed ID: 34233930
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
[TBL] [Abstract][Full Text] [Related]
16. Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.
Zhou G; Cheung AK; Liu X; Huang Y
Clin Sci (Lond); 2014 May; 126(10):707-20. PubMed ID: 24195695
[TBL] [Abstract][Full Text] [Related]
17. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.
Zhang J; Fu H; Xu Y; Niu Y; An X
J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-337 leads to podocyte injury in mice with diabetic nephropathy.
Zhao SM; Zhang T; Qiu Q; Xu C; Ma LJ; Liu J; Wang Z; Li YC; Huang J; Zhang M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8485-8492. PubMed ID: 31646579
[TBL] [Abstract][Full Text] [Related]
19. Macrophages directly mediate diabetic renal injury.
You H; Gao T; Cooper TK; Brian Reeves W; Awad AS
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1719-27. PubMed ID: 24173355
[TBL] [Abstract][Full Text] [Related]
20. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
